Celularity Inc. - Class A Common Stock
Celularity Inc. - Class A Common Stock
Aktie · US1511902041 · CELU (XNAS)
Übersicht Finanzkennzahlen
2,07 USD
7,81 % 0,15 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
06.06.2025 19:59

Aktuelle Kurse von Celularity Inc. - Class A Common Stock

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
CELU
USD
06.06.2025 19:59
2,07 USD
1,92 USD
+7,81 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
0,00 % -6,33 % 21,05 % 61,72 % -10,78 % -36,31 % -97,91 %

Firmenprofil zu Celularity Inc. - Class A Common Stock Aktie

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

Unternehmensdaten

Name Celularity Inc. - Class A Common Stock
Firma Celularity Inc.
Symbol CELU
Website https://www.celularity.com
Heimatbörse XNAS NASDAQ
ISIN US1511902041
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Dr. Robert Joseph Hariri M.D., Ph.D.
Marktkapitalisierung 37 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 0,1 T
Adresse 170 Park Avenue, 07932 Florham Park
IPO Datum 2019-08-08

Kennungs-Wechsel

Datum Von Zu
19.07.2021 GXGX CELU

Ticker Symbole

Name Symbol
NASDAQ CELU

Weitere Aktien

Investoren die Celularity Inc. - Class A Common Stock die halten, haben auch folgende Aktien im Depot:
HSBC BANK PLC NTS LKD EUKAIROS PRF SHS 1063 29/04/24
HSBC BANK PLC NTS LKD EUKAIROS PRF SHS 1063 29/04/24 Anleihe
MINERAL ROAD DISC. O.N.
MINERAL ROAD DISC. O.N. Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025